Skip to content

ARQUENNES PHARMA: what changed

BE 0442.964.356NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€132,377
2024 · €121,830+€10,547
Equity
€238,406
2024 · €236,029+€2,377
Cash
€197,203
2024 · €217,166-€19,963
Balance sheet total
€712,567
2024 · €809,649-€97,081

Largest movements

2024 to 2025
Assets
  • Stocks and contracts -€103,837

    down €103,837 (-37.1%), from €280,044 to €176,207

  • Cash -€19,963

    down €19,963 (-9.2%), from €217,166 to €197,203

    mainly Contributions, distributions and other (-€130,000) and Debts after one year (-€82,689)

  • Receivables within one year +€15,519

    up €15,519 (+12.9%), from €120,452 to €135,971

    of which Other amounts receivable: +€14,924

  • Tangible fixed assets +€11,200

    up €11,200 (+5.8%), from €191,837 to €203,037

    of which Furniture and vehicles: +€23,362

Equity and liabilities
  • Debts after one year -€82,689

    down €82,689 (-26.7%), from €309,912 to €227,223

    of which Other amounts payable: -€56,022

  • Accrued charges and deferred income -€18,233

    no longer reported in 2025; in 2024 it stood at €18,233

  • Tax, wage and social debts +€10,217

    up €10,217 (+6.2%), from €163,559 to €173,776

    of which Remuneration and social security: +€6,359

  • Other debts -€8,839

    no longer reported in 2025; in 2024 it stood at €8,839

Income statement
  • Gross operating margin -€21,044

    down €21,044 (-4.4%), from €483,106 to €462,062

  • Depreciation -€20,275

    down €20,275 (-61.8%), from €32,833 to €12,558

  • Staff costs -€7,186

    down €7,186 (-2.4%), from €294,606 to €287,420

  • Financial charges -€4,836

    down €4,836 (-17.5%), from €27,570 to €22,734

    of which Financial charges: -€4,730

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 €121,830
Gross operating margin -€21,044
Staff costs +€7,186
Depreciation +€20,275
Other operating charges -€305
Financial income -€204
Financial charges +€4,836
Taxes -€198
Result 2025 €132,377
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€216,484
Investment -€23,758
Financing -€212,689
Cash 2024 €217,166
Net result for the year +€132,377
Depreciation +€12,558
Stocks and contracts +€103,837
Receivables within one year -€15,519
Trade debts +€86
Tax, wage and social debts +€10,217
Other debts -€8,839
Accrued charges and deferred income -€18,233
Investment in fixed assets (net) -€23,758
Debts after one year -€82,689
Contributions, distributions and other -€130,000
Cash 2025 €197,203
brings cash intakes cash out
Every line side by side 53 lines
Line Code 2024 2025 Change %
Total assets 20/58 €809,649 €712,567 -€97,081 -12.0%
Fixed assets 21/28 €191,987 €203,187 +€11,200 +5.8%
Tangible fixed assets 22/27 €191,837 €203,037 +€11,200 +5.8%
Land and buildings 22 €176,370 €165,347 -€11,023 -6.2%
Furniture and vehicles 24 - €23,362 +€23,362
Other tangible fixed assets 26 €15,466 €14,328 -€1,139 -7.4%
Financial fixed assets 28 €150 €150 = 0.0%
Current assets 29/58 €617,662 €509,381 -€108,281 -17.5%
Stocks and contracts in progress 3 €280,044 €176,207 -€103,837 -37.1%
Stocks 30/36 €280,044 €176,207 -€103,837 -37.1%
Amounts receivable within one year 40/41 €120,452 €135,971 +€15,519 +12.9%
Trade receivables 40 €4,853 €5,448 +€595 +12.3%
Other amounts receivable 41 €115,599 €130,523 +€14,924 +12.9%
Cash at bank and in hand 54/58 €217,166 €197,203 -€19,963 -9.2%
Total equity and liabilities 10/49 €809,649 €712,567 -€97,081 -12.0%
Equity 10/15 €236,029 €238,406 +€2,377 +1.0%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €64,611 €64,611 = 0.0%
Non-distributable reserves 130/1 €6,200 €6,200 = 0.0%
Legal reserve 130 €6,200 €6,200 = 0.0%
Tax-exempt reserves 132 €12,218 €12,218 = 0.0%
Distributable reserves 133 €46,193 €46,193 = 0.0%
Profit (loss) carried forward 14 €109,418 €111,795 +€2,377 +2.2%
Amounts payable 17/49 €573,620 €474,162 -€99,458 -17.3%
Amounts payable after more than one year 17 €309,912 €227,223 -€82,689 -26.7%
Financial debts 170/4 €82,223 €55,556 -€26,667 -32.4%
Other amounts payable 178/9 €227,690 €171,667 -€56,022 -24.6%
Amounts payable within one year 42/48 €245,475 €246,939 +€1,464 +0.6%
Current portion of amounts payable after more than one year 42 €26,667 €26,667 = 0.0%
Trade debts 44 €46,411 €46,496 +€86 +0.2%
Suppliers 440/4 €46,411 €46,496 +€86 +0.2%
Taxes, remuneration and social security 45 €163,559 €173,776 +€10,217 +6.2%
Taxes 450/3 €2,747 €6,604 +€3,857 +140%
Remuneration and social security 454/9 €160,812 €167,172 +€6,359 +4.0%
Other amounts payable 47/48 €8,839 - -€8,839
Accrued charges and deferred income 492/3 €18,233 - -€18,233
Remuneration, social security and pensions 62 €294,606 €287,420 -€7,186 -2.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €32,833 €12,558 -€20,275 -61.8%
Other operating charges 640/8 €3,844 €4,149 +€305 +7.9%
Gross operating margin 9900 €483,106 €462,062 -€21,044 -4.4%
Operating profit (loss) 9901 €151,823 €157,935 +€6,112 +4.0%
Financial income 75/76B €204 €0 -€204 -99.8%
Recurring financial income 75 €22 €0 -€21 -98.4%
Non-recurring financial income 76B €182 - -€182
Financial charges 65/66B €27,570 €22,734 -€4,836 -17.5%
Recurring financial charges 65 €27,464 €22,734 -€4,730 -17.2%
Non-recurring financial charges 66B €106 - -€106
Profit (loss) for the period before taxes 9903 €124,457 €135,201 +€10,744 +8.6%
Income taxes 67/77 €2,627 €2,824 +€198 +7.5%
Profit (loss) for the period 9904 €121,830 €132,377 +€10,547 +8.7%
Profit (loss) for the period to be appropriated 9905 €121,830 €132,377 +€10,547 +8.7%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€473,542 to €615,278

Midpoint €532,599 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity €238,406
Capitalised earnings €708,679 to €992,150
Indication €473,542 to €615,278

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€238,406
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€238,406

Capitalised earnings

net result for the year (9904)
2025
€132,377
2024
€121,830
excluding non-recurring income and charges
€121,754
2023
€43,515
2022
€67,400
2021
€69,233
Average result, excluding non-recurring income and charges
€99,215
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€708,679 / €826,792 / €992,150

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 21 November 2026 via checked.be.